Cargando…
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain tumour in humans and has a very poor prognosis. The existing treatments have had limited success in increasing overall survival. Thus, identifying and understanding the key molecule(s) responsible for the maligna...
Autores principales: | Taylor, Olivia G., Brzozowski, Joshua S., Skelding, Kathryn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775189/ https://www.ncbi.nlm.nih.gov/pubmed/31616641 http://dx.doi.org/10.3389/fonc.2019.00963 |
Ejemplares similares
-
The Multi-Functional Calcium/Calmodulin Stimulated Protein Kinase (CaMK) Family: Emerging Targets for Anti-Cancer Therapeutic Intervention
por: Brzozowski, Joshua S., et al.
Publicado: (2019) -
Cytomegalovirus as a Novel Target for Immunotherapy of Glioblastoma Multiforme
por: Schuessler, Andrea, et al.
Publicado: (2014) -
Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014) -
Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
por: Chin, Christopher, et al.
Publicado: (2018) -
An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
por: Teraiya, Milan, et al.
Publicado: (2023)